A Study Of Diflucan In Children With Ringworm Of The Scalp
Completed · Phase 3
Conditions studied: Tinea Capitis
In brief
The purpose of this study is to evaluate the safety and efficacy of fluconazole for the treatment of tinea capitis in pediatric patients aged 3 to 12 years.
Key facts
- Study ID
- NCT00645242
- Run by
- Pfizer
- People needed
- 185
- Starts
- 2002-11-01
- Expected to finish
- 2003-03-01
- Last updated by the study team
- 2021-07-16
Who can join
Age: 3 and older, up to 12. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Pediatric patients (aged 3-12 years)
- Clinical diagnosis of tinea capitis
- Direct microscopy (KOH) positive for fungal elements within or outside hair shaft
You may not qualify if…
- Negative baseline KOH
- Liver disease
Where it is running
- Pfizer Investigational Site — Montgomery, Alabama, United States
- Pfizer Investigational Site — Little Rock, Arkansas, United States
- Pfizer Investigational Site — San Diego, California, United States
- Pfizer Investigational Site — Miami, Florida, United States
- Pfizer Investigational Site — Miami, Florida, United States
- Pfizer Investigational Site — Martinez, Georgia, United States
- Pfizer Investigational Site — Chicago, Illinois, United States
- Pfizer Investigational Site — Evanston, Illinois, United States
- Pfizer Investigational Site — Gretna, Louisiana, United States
- Pfizer Investigational Site — New Orleans, Louisiana, United States
- Pfizer Investigational Site — Shreveport, Louisiana, United States
- Pfizer Investigational Site — Detroit, Michigan, United States
- Pfizer Investigational Site — Fridley, Minnesota, United States
- Pfizer Investigational Site — Bridgeton, Missouri, United States
- Pfizer Investigational Site — Brooklyn, New York, United States
- Pfizer Investigational Site — Garner, North Carolina, United States
- Pfizer Investigational Site — Raleigh, North Carolina, United States
- Pfizer Investigational Site — Cleveland, Ohio, United States
- Pfizer Investigational Site — Columbus, Ohio, United States
- Pfizer Investigational Site — Mt. Pleasant, South Carolina, United States
- Pfizer Investigational Site — Knoxville, Tennessee, United States
- Pfizer Investigational Site — Murfreesboro, Tennessee, United States
- Pfizer Investigational Site — Nashville, Tennessee, United States
- Pfizer Investigational Site — Houston, Texas, United States
- Pfizer Investigational Site — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.